Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion, a dedicated life sciences venture capital firm headquartered in the Netherlands with a long track record in European biotechnology and healthcare investing. The SPAC completed its IPO in 2021 targeting acquisition opportunities in the life sciences and healthcare sector, with a stated emphasis on European-rooted companies. The company filed an amended quarterly report on Form 10-Q/A with the SEC on March 10, 2023, accession number 0001193125-23-066323, reflecting updated disclosures for its reporting period. As of that filing date, FRBN remained in its search phase. Sign up at SpacDesk for full filing history, timeline data, and deal-status tracking on FRBN and hundreds of other SPACs.